Global Oncolytic Virus Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Oncolytic Virus Service market size was valued at USD 66110 million in 2023 and is forecast to a readjusted size of USD 235580 million by 2030 with a CAGR of 19.9% during review period.
The main contents of oncolytic virus services include virus screening, virus production, quality testing, drug efficacy evaluation, etc. In this process, pharmaceutical companies can select different virus strains and, after appropriate genetic engineering, be used to treat different types of tumors.
With the continuous development of gene editing technology and viral vector technology, more new oncolytic viruses will be developed, providing more options for tumor treatment.
The Global Info Research report includes an overview of the development of the Oncolytic Virus Service industry chain, the market status of Tumor Treatment (Measles Virus (MeV), Herpes Simplex Virus (HSV-1)), Scientific Research (Measles Virus (MeV), Herpes Simplex Virus (HSV-1)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus Service.
Regionally, the report analyzes the Oncolytic Virus Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Virus Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus Service industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Measles Virus (MeV), Herpes Simplex Virus (HSV-1)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus Service market.
Regional Analysis: The report involves examining the Oncolytic Virus Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Virus Service:
Company Analysis: Report covers individual Oncolytic Virus Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Tumor Treatment, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus Service. It assesses the current state, advancements, and potential future developments in Oncolytic Virus Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Virus Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Oncolytic Virus Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Service, with revenue, gross margin and global market share of Oncolytic Virus Service from 2019 to 2024.
Chapter 3, the Oncolytic Virus Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus Service market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Service.
Chapter 13, to describe Oncolytic Virus Service research findings and conclusion.
The main contents of oncolytic virus services include virus screening, virus production, quality testing, drug efficacy evaluation, etc. In this process, pharmaceutical companies can select different virus strains and, after appropriate genetic engineering, be used to treat different types of tumors.
With the continuous development of gene editing technology and viral vector technology, more new oncolytic viruses will be developed, providing more options for tumor treatment.
The Global Info Research report includes an overview of the development of the Oncolytic Virus Service industry chain, the market status of Tumor Treatment (Measles Virus (MeV), Herpes Simplex Virus (HSV-1)), Scientific Research (Measles Virus (MeV), Herpes Simplex Virus (HSV-1)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus Service.
Regionally, the report analyzes the Oncolytic Virus Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Virus Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus Service industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Measles Virus (MeV), Herpes Simplex Virus (HSV-1)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus Service market.
Regional Analysis: The report involves examining the Oncolytic Virus Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Virus Service:
Company Analysis: Report covers individual Oncolytic Virus Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Tumor Treatment, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus Service. It assesses the current state, advancements, and potential future developments in Oncolytic Virus Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Virus Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Measles Virus (MeV)
- Herpes Simplex Virus (HSV-1)
- Others
- Tumor Treatment
- Scientific Research
- Creative Biolabs
- Creative Biogene
- Recipharm
- Nabios
- IDT Biologika
- FUJIFILM Diosynth Biotechnologies
- Exothera
- Lonza
- ABL
- Takara Bio
- Libentech
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Oncolytic Virus Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Service, with revenue, gross margin and global market share of Oncolytic Virus Service from 2019 to 2024.
Chapter 3, the Oncolytic Virus Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus Service market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Service.
Chapter 13, to describe Oncolytic Virus Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oncolytic Virus Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus Service by Type
1.3.1 Overview: Global Oncolytic Virus Service Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncolytic Virus Service Consumption Value Market Share by Type in 2023
1.3.3 Measles Virus (MeV)
1.3.4 Herpes Simplex Virus (HSV-1)
1.3.5 Others
1.4 Global Oncolytic Virus Service Market by Application
1.4.1 Overview: Global Oncolytic Virus Service Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Tumor Treatment
1.4.3 Scientific Research
1.5 Global Oncolytic Virus Service Market Size & Forecast
1.6 Global Oncolytic Virus Service Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Service Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncolytic Virus Service Market Size by Region, (2019-2030)
1.6.3 North America Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.4 Europe Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.6 South America Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncolytic Virus Service Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Creative Biolabs
2.1.1 Creative Biolabs Details
2.1.2 Creative Biolabs Major Business
2.1.3 Creative Biolabs Oncolytic Virus Service Product and Solutions
2.1.4 Creative Biolabs Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Creative Biolabs Recent Developments and Future Plans
2.2 Creative Biogene
2.2.1 Creative Biogene Details
2.2.2 Creative Biogene Major Business
2.2.3 Creative Biogene Oncolytic Virus Service Product and Solutions
2.2.4 Creative Biogene Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Creative Biogene Recent Developments and Future Plans
2.3 Recipharm
2.3.1 Recipharm Details
2.3.2 Recipharm Major Business
2.3.3 Recipharm Oncolytic Virus Service Product and Solutions
2.3.4 Recipharm Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Recipharm Recent Developments and Future Plans
2.4 Nabios
2.4.1 Nabios Details
2.4.2 Nabios Major Business
2.4.3 Nabios Oncolytic Virus Service Product and Solutions
2.4.4 Nabios Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nabios Recent Developments and Future Plans
2.5 IDT Biologika
2.5.1 IDT Biologika Details
2.5.2 IDT Biologika Major Business
2.5.3 IDT Biologika Oncolytic Virus Service Product and Solutions
2.5.4 IDT Biologika Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 IDT Biologika Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Exothera
2.7.1 Exothera Details
2.7.2 Exothera Major Business
2.7.3 Exothera Oncolytic Virus Service Product and Solutions
2.7.4 Exothera Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Exothera Recent Developments and Future Plans
2.8 Lonza
2.8.1 Lonza Details
2.8.2 Lonza Major Business
2.8.3 Lonza Oncolytic Virus Service Product and Solutions
2.8.4 Lonza Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lonza Recent Developments and Future Plans
2.9 ABL
2.9.1 ABL Details
2.9.2 ABL Major Business
2.9.3 ABL Oncolytic Virus Service Product and Solutions
2.9.4 ABL Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ABL Recent Developments and Future Plans
2.10 Takara Bio
2.10.1 Takara Bio Details
2.10.2 Takara Bio Major Business
2.10.3 Takara Bio Oncolytic Virus Service Product and Solutions
2.10.4 Takara Bio Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Takara Bio Recent Developments and Future Plans
2.11 Libentech
2.11.1 Libentech Details
2.11.2 Libentech Major Business
2.11.3 Libentech Oncolytic Virus Service Product and Solutions
2.11.4 Libentech Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Libentech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncolytic Virus Service Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Oncolytic Virus Service by Company Revenue
3.2.2 Top 3 Oncolytic Virus Service Players Market Share in 2023
3.2.3 Top 6 Oncolytic Virus Service Players Market Share in 2023
3.3 Oncolytic Virus Service Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Service Market: Region Footprint
3.3.2 Oncolytic Virus Service Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncolytic Virus Service Consumption Value and Market Share by Type (2019-2024)
4.2 Global Oncolytic Virus Service Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncolytic Virus Service Consumption Value Market Share by Application (2019-2024)
5.2 Global Oncolytic Virus Service Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Oncolytic Virus Service Consumption Value by Type (2019-2030)
6.2 North America Oncolytic Virus Service Consumption Value by Application (2019-2030)
6.3 North America Oncolytic Virus Service Market Size by Country
6.3.1 North America Oncolytic Virus Service Consumption Value by Country (2019-2030)
6.3.2 United States Oncolytic Virus Service Market Size and Forecast (2019-2030)
6.3.3 Canada Oncolytic Virus Service Market Size and Forecast (2019-2030)
6.3.4 Mexico Oncolytic Virus Service Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Oncolytic Virus Service Consumption Value by Type (2019-2030)
7.2 Europe Oncolytic Virus Service Consumption Value by Application (2019-2030)
7.3 Europe Oncolytic Virus Service Market Size by Country
7.3.1 Europe Oncolytic Virus Service Consumption Value by Country (2019-2030)
7.3.2 Germany Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.3 France Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.5 Russia Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.6 Italy Oncolytic Virus Service Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncolytic Virus Service Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Service Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncolytic Virus Service Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Service Consumption Value by Region (2019-2030)
8.3.2 China Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.3 Japan Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.4 South Korea Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.5 India Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.7 Australia Oncolytic Virus Service Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Oncolytic Virus Service Consumption Value by Type (2019-2030)
9.2 South America Oncolytic Virus Service Consumption Value by Application (2019-2030)
9.3 South America Oncolytic Virus Service Market Size by Country
9.3.1 South America Oncolytic Virus Service Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncolytic Virus Service Market Size and Forecast (2019-2030)
9.3.3 Argentina Oncolytic Virus Service Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncolytic Virus Service Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Service Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncolytic Virus Service Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Service Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncolytic Virus Service Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncolytic Virus Service Market Size and Forecast (2019-2030)
10.3.4 UAE Oncolytic Virus Service Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Oncolytic Virus Service Market Drivers
11.2 Oncolytic Virus Service Market Restraints
11.3 Oncolytic Virus Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncolytic Virus Service Industry Chain
12.2 Oncolytic Virus Service Upstream Analysis
12.3 Oncolytic Virus Service Midstream Analysis
12.4 Oncolytic Virus Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Oncolytic Virus Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus Service by Type
1.3.1 Overview: Global Oncolytic Virus Service Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncolytic Virus Service Consumption Value Market Share by Type in 2023
1.3.3 Measles Virus (MeV)
1.3.4 Herpes Simplex Virus (HSV-1)
1.3.5 Others
1.4 Global Oncolytic Virus Service Market by Application
1.4.1 Overview: Global Oncolytic Virus Service Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Tumor Treatment
1.4.3 Scientific Research
1.5 Global Oncolytic Virus Service Market Size & Forecast
1.6 Global Oncolytic Virus Service Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Service Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncolytic Virus Service Market Size by Region, (2019-2030)
1.6.3 North America Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.4 Europe Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.6 South America Oncolytic Virus Service Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncolytic Virus Service Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Creative Biolabs
2.1.1 Creative Biolabs Details
2.1.2 Creative Biolabs Major Business
2.1.3 Creative Biolabs Oncolytic Virus Service Product and Solutions
2.1.4 Creative Biolabs Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Creative Biolabs Recent Developments and Future Plans
2.2 Creative Biogene
2.2.1 Creative Biogene Details
2.2.2 Creative Biogene Major Business
2.2.3 Creative Biogene Oncolytic Virus Service Product and Solutions
2.2.4 Creative Biogene Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Creative Biogene Recent Developments and Future Plans
2.3 Recipharm
2.3.1 Recipharm Details
2.3.2 Recipharm Major Business
2.3.3 Recipharm Oncolytic Virus Service Product and Solutions
2.3.4 Recipharm Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Recipharm Recent Developments and Future Plans
2.4 Nabios
2.4.1 Nabios Details
2.4.2 Nabios Major Business
2.4.3 Nabios Oncolytic Virus Service Product and Solutions
2.4.4 Nabios Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nabios Recent Developments and Future Plans
2.5 IDT Biologika
2.5.1 IDT Biologika Details
2.5.2 IDT Biologika Major Business
2.5.3 IDT Biologika Oncolytic Virus Service Product and Solutions
2.5.4 IDT Biologika Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 IDT Biologika Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Exothera
2.7.1 Exothera Details
2.7.2 Exothera Major Business
2.7.3 Exothera Oncolytic Virus Service Product and Solutions
2.7.4 Exothera Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Exothera Recent Developments and Future Plans
2.8 Lonza
2.8.1 Lonza Details
2.8.2 Lonza Major Business
2.8.3 Lonza Oncolytic Virus Service Product and Solutions
2.8.4 Lonza Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lonza Recent Developments and Future Plans
2.9 ABL
2.9.1 ABL Details
2.9.2 ABL Major Business
2.9.3 ABL Oncolytic Virus Service Product and Solutions
2.9.4 ABL Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ABL Recent Developments and Future Plans
2.10 Takara Bio
2.10.1 Takara Bio Details
2.10.2 Takara Bio Major Business
2.10.3 Takara Bio Oncolytic Virus Service Product and Solutions
2.10.4 Takara Bio Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Takara Bio Recent Developments and Future Plans
2.11 Libentech
2.11.1 Libentech Details
2.11.2 Libentech Major Business
2.11.3 Libentech Oncolytic Virus Service Product and Solutions
2.11.4 Libentech Oncolytic Virus Service Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Libentech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncolytic Virus Service Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Oncolytic Virus Service by Company Revenue
3.2.2 Top 3 Oncolytic Virus Service Players Market Share in 2023
3.2.3 Top 6 Oncolytic Virus Service Players Market Share in 2023
3.3 Oncolytic Virus Service Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Service Market: Region Footprint
3.3.2 Oncolytic Virus Service Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncolytic Virus Service Consumption Value and Market Share by Type (2019-2024)
4.2 Global Oncolytic Virus Service Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncolytic Virus Service Consumption Value Market Share by Application (2019-2024)
5.2 Global Oncolytic Virus Service Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Oncolytic Virus Service Consumption Value by Type (2019-2030)
6.2 North America Oncolytic Virus Service Consumption Value by Application (2019-2030)
6.3 North America Oncolytic Virus Service Market Size by Country
6.3.1 North America Oncolytic Virus Service Consumption Value by Country (2019-2030)
6.3.2 United States Oncolytic Virus Service Market Size and Forecast (2019-2030)
6.3.3 Canada Oncolytic Virus Service Market Size and Forecast (2019-2030)
6.3.4 Mexico Oncolytic Virus Service Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Oncolytic Virus Service Consumption Value by Type (2019-2030)
7.2 Europe Oncolytic Virus Service Consumption Value by Application (2019-2030)
7.3 Europe Oncolytic Virus Service Market Size by Country
7.3.1 Europe Oncolytic Virus Service Consumption Value by Country (2019-2030)
7.3.2 Germany Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.3 France Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.5 Russia Oncolytic Virus Service Market Size and Forecast (2019-2030)
7.3.6 Italy Oncolytic Virus Service Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncolytic Virus Service Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Service Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncolytic Virus Service Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Service Consumption Value by Region (2019-2030)
8.3.2 China Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.3 Japan Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.4 South Korea Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.5 India Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncolytic Virus Service Market Size and Forecast (2019-2030)
8.3.7 Australia Oncolytic Virus Service Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Oncolytic Virus Service Consumption Value by Type (2019-2030)
9.2 South America Oncolytic Virus Service Consumption Value by Application (2019-2030)
9.3 South America Oncolytic Virus Service Market Size by Country
9.3.1 South America Oncolytic Virus Service Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncolytic Virus Service Market Size and Forecast (2019-2030)
9.3.3 Argentina Oncolytic Virus Service Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncolytic Virus Service Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Service Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncolytic Virus Service Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Service Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncolytic Virus Service Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncolytic Virus Service Market Size and Forecast (2019-2030)
10.3.4 UAE Oncolytic Virus Service Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Oncolytic Virus Service Market Drivers
11.2 Oncolytic Virus Service Market Restraints
11.3 Oncolytic Virus Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncolytic Virus Service Industry Chain
12.2 Oncolytic Virus Service Upstream Analysis
12.3 Oncolytic Virus Service Midstream Analysis
12.4 Oncolytic Virus Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncolytic Virus Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oncolytic Virus Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Oncolytic Virus Service Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Oncolytic Virus Service Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 6. Creative Biolabs Major Business
Table 7. Creative Biolabs Oncolytic Virus Service Product and Solutions
Table 8. Creative Biolabs Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Creative Biolabs Recent Developments and Future Plans
Table 10. Creative Biogene Company Information, Head Office, and Major Competitors
Table 11. Creative Biogene Major Business
Table 12. Creative Biogene Oncolytic Virus Service Product and Solutions
Table 13. Creative Biogene Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Creative Biogene Recent Developments and Future Plans
Table 15. Recipharm Company Information, Head Office, and Major Competitors
Table 16. Recipharm Major Business
Table 17. Recipharm Oncolytic Virus Service Product and Solutions
Table 18. Recipharm Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Recipharm Recent Developments and Future Plans
Table 20. Nabios Company Information, Head Office, and Major Competitors
Table 21. Nabios Major Business
Table 22. Nabios Oncolytic Virus Service Product and Solutions
Table 23. Nabios Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Nabios Recent Developments and Future Plans
Table 25. IDT Biologika Company Information, Head Office, and Major Competitors
Table 26. IDT Biologika Major Business
Table 27. IDT Biologika Oncolytic Virus Service Product and Solutions
Table 28. IDT Biologika Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. IDT Biologika Recent Developments and Future Plans
Table 30. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 31. FUJIFILM Diosynth Biotechnologies Major Business
Table 32. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product and Solutions
Table 33. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 35. Exothera Company Information, Head Office, and Major Competitors
Table 36. Exothera Major Business
Table 37. Exothera Oncolytic Virus Service Product and Solutions
Table 38. Exothera Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Exothera Recent Developments and Future Plans
Table 40. Lonza Company Information, Head Office, and Major Competitors
Table 41. Lonza Major Business
Table 42. Lonza Oncolytic Virus Service Product and Solutions
Table 43. Lonza Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Lonza Recent Developments and Future Plans
Table 45. ABL Company Information, Head Office, and Major Competitors
Table 46. ABL Major Business
Table 47. ABL Oncolytic Virus Service Product and Solutions
Table 48. ABL Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. ABL Recent Developments and Future Plans
Table 50. Takara Bio Company Information, Head Office, and Major Competitors
Table 51. Takara Bio Major Business
Table 52. Takara Bio Oncolytic Virus Service Product and Solutions
Table 53. Takara Bio Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Takara Bio Recent Developments and Future Plans
Table 55. Libentech Company Information, Head Office, and Major Competitors
Table 56. Libentech Major Business
Table 57. Libentech Oncolytic Virus Service Product and Solutions
Table 58. Libentech Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Libentech Recent Developments and Future Plans
Table 60. Global Oncolytic Virus Service Revenue (USD Million) by Players (2019-2024)
Table 61. Global Oncolytic Virus Service Revenue Share by Players (2019-2024)
Table 62. Breakdown of Oncolytic Virus Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Oncolytic Virus Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Oncolytic Virus Service Players
Table 65. Oncolytic Virus Service Market: Company Product Type Footprint
Table 66. Oncolytic Virus Service Market: Company Product Application Footprint
Table 67. Oncolytic Virus Service New Market Entrants and Barriers to Market Entry
Table 68. Oncolytic Virus Service Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Oncolytic Virus Service Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Oncolytic Virus Service Consumption Value Share by Type (2019-2024)
Table 71. Global Oncolytic Virus Service Consumption Value Forecast by Type (2025-2030)
Table 72. Global Oncolytic Virus Service Consumption Value by Application (2019-2024)
Table 73. Global Oncolytic Virus Service Consumption Value Forecast by Application (2025-2030)
Table 74. North America Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Oncolytic Virus Service Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Oncolytic Virus Service Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Oncolytic Virus Service Raw Material
Table 105. Key Suppliers of Oncolytic Virus Service Raw Materials
Table 1. Global Oncolytic Virus Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oncolytic Virus Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Oncolytic Virus Service Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Oncolytic Virus Service Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 6. Creative Biolabs Major Business
Table 7. Creative Biolabs Oncolytic Virus Service Product and Solutions
Table 8. Creative Biolabs Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Creative Biolabs Recent Developments and Future Plans
Table 10. Creative Biogene Company Information, Head Office, and Major Competitors
Table 11. Creative Biogene Major Business
Table 12. Creative Biogene Oncolytic Virus Service Product and Solutions
Table 13. Creative Biogene Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Creative Biogene Recent Developments and Future Plans
Table 15. Recipharm Company Information, Head Office, and Major Competitors
Table 16. Recipharm Major Business
Table 17. Recipharm Oncolytic Virus Service Product and Solutions
Table 18. Recipharm Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Recipharm Recent Developments and Future Plans
Table 20. Nabios Company Information, Head Office, and Major Competitors
Table 21. Nabios Major Business
Table 22. Nabios Oncolytic Virus Service Product and Solutions
Table 23. Nabios Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Nabios Recent Developments and Future Plans
Table 25. IDT Biologika Company Information, Head Office, and Major Competitors
Table 26. IDT Biologika Major Business
Table 27. IDT Biologika Oncolytic Virus Service Product and Solutions
Table 28. IDT Biologika Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. IDT Biologika Recent Developments and Future Plans
Table 30. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 31. FUJIFILM Diosynth Biotechnologies Major Business
Table 32. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product and Solutions
Table 33. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 35. Exothera Company Information, Head Office, and Major Competitors
Table 36. Exothera Major Business
Table 37. Exothera Oncolytic Virus Service Product and Solutions
Table 38. Exothera Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Exothera Recent Developments and Future Plans
Table 40. Lonza Company Information, Head Office, and Major Competitors
Table 41. Lonza Major Business
Table 42. Lonza Oncolytic Virus Service Product and Solutions
Table 43. Lonza Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Lonza Recent Developments and Future Plans
Table 45. ABL Company Information, Head Office, and Major Competitors
Table 46. ABL Major Business
Table 47. ABL Oncolytic Virus Service Product and Solutions
Table 48. ABL Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. ABL Recent Developments and Future Plans
Table 50. Takara Bio Company Information, Head Office, and Major Competitors
Table 51. Takara Bio Major Business
Table 52. Takara Bio Oncolytic Virus Service Product and Solutions
Table 53. Takara Bio Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Takara Bio Recent Developments and Future Plans
Table 55. Libentech Company Information, Head Office, and Major Competitors
Table 56. Libentech Major Business
Table 57. Libentech Oncolytic Virus Service Product and Solutions
Table 58. Libentech Oncolytic Virus Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Libentech Recent Developments and Future Plans
Table 60. Global Oncolytic Virus Service Revenue (USD Million) by Players (2019-2024)
Table 61. Global Oncolytic Virus Service Revenue Share by Players (2019-2024)
Table 62. Breakdown of Oncolytic Virus Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Oncolytic Virus Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Oncolytic Virus Service Players
Table 65. Oncolytic Virus Service Market: Company Product Type Footprint
Table 66. Oncolytic Virus Service Market: Company Product Application Footprint
Table 67. Oncolytic Virus Service New Market Entrants and Barriers to Market Entry
Table 68. Oncolytic Virus Service Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Oncolytic Virus Service Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Oncolytic Virus Service Consumption Value Share by Type (2019-2024)
Table 71. Global Oncolytic Virus Service Consumption Value Forecast by Type (2025-2030)
Table 72. Global Oncolytic Virus Service Consumption Value by Application (2019-2024)
Table 73. Global Oncolytic Virus Service Consumption Value Forecast by Application (2025-2030)
Table 74. North America Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Oncolytic Virus Service Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Oncolytic Virus Service Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Oncolytic Virus Service Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Oncolytic Virus Service Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Oncolytic Virus Service Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Oncolytic Virus Service Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Oncolytic Virus Service Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Oncolytic Virus Service Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Oncolytic Virus Service Raw Material
Table 105. Key Suppliers of Oncolytic Virus Service Raw Materials
LIST OF FIGURES
Figure 1. Oncolytic Virus Service Picture
Figure 2. Global Oncolytic Virus Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oncolytic Virus Service Consumption Value Market Share by Type in 2023
Figure 4. Measles Virus (MeV)
Figure 5. Herpes Simplex Virus (HSV-1)
Figure 6. Others
Figure 7. Global Oncolytic Virus Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Oncolytic Virus Service Consumption Value Market Share by Application in 2023
Figure 9. Tumor Treatment Picture
Figure 10. Scientific Research Picture
Figure 11. Global Oncolytic Virus Service Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Oncolytic Virus Service Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Oncolytic Virus Service Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Oncolytic Virus Service Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Oncolytic Virus Service Consumption Value Market Share by Region in 2023
Figure 16. North America Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Oncolytic Virus Service Revenue Share by Players in 2023
Figure 22. Oncolytic Virus Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Oncolytic Virus Service Market Share in 2023
Figure 24. Global Top 6 Players Oncolytic Virus Service Market Share in 2023
Figure 25. Global Oncolytic Virus Service Consumption Value Share by Type (2019-2024)
Figure 26. Global Oncolytic Virus Service Market Share Forecast by Type (2025-2030)
Figure 27. Global Oncolytic Virus Service Consumption Value Share by Application (2019-2024)
Figure 28. Global Oncolytic Virus Service Market Share Forecast by Application (2025-2030)
Figure 29. North America Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 39. France Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Oncolytic Virus Service Consumption Value Market Share by Region (2019-2030)
Figure 46. China Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 49. India Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 63. Oncolytic Virus Service Market Drivers
Figure 64. Oncolytic Virus Service Market Restraints
Figure 65. Oncolytic Virus Service Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Oncolytic Virus Service in 2023
Figure 68. Manufacturing Process Analysis of Oncolytic Virus Service
Figure 69. Oncolytic Virus Service Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Oncolytic Virus Service Picture
Figure 2. Global Oncolytic Virus Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oncolytic Virus Service Consumption Value Market Share by Type in 2023
Figure 4. Measles Virus (MeV)
Figure 5. Herpes Simplex Virus (HSV-1)
Figure 6. Others
Figure 7. Global Oncolytic Virus Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Oncolytic Virus Service Consumption Value Market Share by Application in 2023
Figure 9. Tumor Treatment Picture
Figure 10. Scientific Research Picture
Figure 11. Global Oncolytic Virus Service Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Oncolytic Virus Service Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Oncolytic Virus Service Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Oncolytic Virus Service Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Oncolytic Virus Service Consumption Value Market Share by Region in 2023
Figure 16. North America Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Oncolytic Virus Service Revenue Share by Players in 2023
Figure 22. Oncolytic Virus Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Oncolytic Virus Service Market Share in 2023
Figure 24. Global Top 6 Players Oncolytic Virus Service Market Share in 2023
Figure 25. Global Oncolytic Virus Service Consumption Value Share by Type (2019-2024)
Figure 26. Global Oncolytic Virus Service Market Share Forecast by Type (2025-2030)
Figure 27. Global Oncolytic Virus Service Consumption Value Share by Application (2019-2024)
Figure 28. Global Oncolytic Virus Service Market Share Forecast by Application (2025-2030)
Figure 29. North America Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 39. France Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Oncolytic Virus Service Consumption Value Market Share by Region (2019-2030)
Figure 46. China Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 49. India Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Oncolytic Virus Service Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Oncolytic Virus Service Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Oncolytic Virus Service Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Oncolytic Virus Service Consumption Value (2019-2030) & (USD Million)
Figure 63. Oncolytic Virus Service Market Drivers
Figure 64. Oncolytic Virus Service Market Restraints
Figure 65. Oncolytic Virus Service Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Oncolytic Virus Service in 2023
Figure 68. Manufacturing Process Analysis of Oncolytic Virus Service
Figure 69. Oncolytic Virus Service Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
